JnJ gets CDSCO panel nod for COVID vaccine study in 12-17 year old Medical Dialogues Team27 Nov 2021 5:59 PM ISTNew Delhi: In order to achieve the unmet medical need in the treatment of COVID-19, the Subject Expert Committee (SEC) functional under the Central...
Pfizer gets CDSCO panel nod to study PF-07321332 for COVID treatment Medical Dialogues Team26 Nov 2021 7:09 PM ISTNew Delhi: In a significant development, pharmaceutical major Pfizer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 25/November/2021 Roshni Dhar25 Nov 2021 6:15 PM ISTHere are Top Health stories of the dayDoctors Shortage In Govt Run Hospitals: Delhi High Court Issues Notice On Plea For Filling Vacancies as soon as...
CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 6:02 PM ISTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Sun Pharma Dapagliflozin, Glimepiride, Metformin FDC gets CDSCO panel nod for phase 3 trial Medical Dialogues Team24 Nov 2021 6:28 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel allows Novartis to waiver conditions for study of anti malarial drug Cipargamin Medical Dialogues Team23 Nov 2021 5:59 PM ISTNew Delhi: Based on the justification provided by the pharma major Novartis, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 22/November/2021 Roshni Dhar22 Nov 2021 5:51 PM ISTHere are Top Health stories of the dayPatient dies of Hemorrhagic shock post LSCS: Consumer Court holds medical negligence by doctor, hospital,...
Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC Medical Dialogues Team22 Nov 2021 5:34 PM ISTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis gets CDSCO panel go ahead for Asciminib Phase 3 trial Roshni Dhar21 Nov 2021 5:18 PM ISTIn a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
Health Bulletin 20/November/2021 Roshni Dhar20 Nov 2021 4:17 PM ISTHere are Top Health stories of the dayDuty of Medical Council to ensure that doctors do not indulge in offences: Madras HCHolding that it is the duty...
CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
